BE VONVENDI® VIBRANT
EMBRACE LIFE IN FULL COLOR
Experience bleed control with VONVENDI, the first and only recombinant VWD treatment.
Created specifically to treat VWD bleeding episodes
VONVENDI® has approved uses in adults and children with von Willebrand disease (VWD), an inherited bleeding disorder that makes it difficult to form blood clots. VONVENDI first received FDA approval for on-demand treatment and control of bleeding episodes in adults in 2015 and has 10 years of real-world use.
VONVENDI is the first and only recombinant treatment for VWD, meaning it's made without using human blood. This technology avoids the risk of spreading diseases through infected human blood.
VONVENDI is approved for 3 uses, including:
- On-demand treatment and control of bleeding episodes in adults and children
- Perioperative management of surgical bleeding in adults and children
- Routine prophylaxis to reduce the frequency of bleeding episodes in adults
Living with von Willebrand disease
VWD can change your life, and no one knows that experience better than the people who face it every day.
Use as prophylaxis
In adults with von Willebrand disease, VONVENDI is approved to reduce the frequency of bleeding episodes.
Try for free
You may be eligible to try VONVENDI for free with our FREEDOM OF CHOICE™ program.